Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Plos One|April 5, 2013
Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancerMark W Zimmerman, Gregg E Homanics, John S LazoCell Reports. Medicine|May 18, 2022
Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insightsNoha A M Shendy, Mark W Zimmerman, Brian J Abraham, et al.Bio-Protocol|November 11, 2024
Accurate Measurement of Cell Number-Normalized Differential Gene Expression in Cells Treated With Retinoic AcidNina Weichert-Leahey, Mark W Zimmerman, Alla Berezovskaya, et al.British Journal of Haematology|February 6, 2023
Synthetic lethal targeting of TET2-mutant haematopoietic stem and progenitor cells by XPO1 inhibitorsChang-Bin Jing, Nicole Prutsch, Shuning He, et al.Stem Cell Research|June 21, 2014
Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in miceJulie M Cramer, Mark W Zimmerman, Tim Thompson, et al.Science Advances|August 25, 2020
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expressionHui Shi, Ting Tao, Brian J Abraham, et al.The Journal of Biological Chemistry|January 10, 2014
Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motilityMark W Zimmerman, Kelley E McQueeney, Jeffrey S Isenberg, et al.Plos Genetics|April 11, 2019
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignanciesFelix Oppel, Ting Tao, Hui Shi, et al.Disease Models & Mechanisms|July 12, 2020
suz12 inactivation in p53- and nf1-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor typesFelix Oppel, Dong H Ki, Mark W Zimmerman, et al.Molecular Cancer Therapeutics|September 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 InhibitionFelix Oppel, Senyao Shao, Sarah Gendreizig, et al.Pageof 3